Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) will report first quarter 2026 financial results and provide a corporate update before markets open on Thursday, May 7, 2026 at 8:30 am ET. The company will host a conference call and live webcast; registration and replay links are available on the investor website.

Praxis will also present at the Bank of America Securities Health Care Conference on Tuesday, May 12, 2026 at 7:20 pm EDT, with a live webcast and a replay available for approximately 90 days.

News Market Reaction – PRAX

-1.28%

2 alerts

-1.28% Session close to close

$9.43B Market Cap

0.0x Rel. Volume

In the May 5 session, PRAX declined 1.28%, reflecting a mild negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules Praxis’s Q1 2026 earnings release for May 7, 2026 and highlights a Bank ...

Analysis

This announcement schedules Praxis’s Q1 2026 earnings release for May 7, 2026 and highlights a Bank of America healthcare conference presentation on May 12, 2026. In the recent past, a similar "conferences,earnings date" notice coincided with only a 0.29% move, suggesting such updates mainly frame upcoming catalysts rather than drive major repricing. Investors may focus on how the call and conference commentary contextualize recent NDA acceptances, positive trial data, and balance‑sheet strength.

Key Figures

Q1 2026 period end: March 31, 2026 Earnings release date: May 7, 2026 Earnings call time: 8:30 am ET +3 more

6 metrics

Q1 2026 period end March 31, 2026 Quarter for upcoming financial results

Earnings release date May 7, 2026 Q1 2026 results and corporate update before market open

Earnings call time 8:30 am ET Start time for Q1 2026 conference call and webcast

Conference presentation date May 12, 2026 Bank of America Securities Health Care Conference presentation

Conference presentation time 7:20 pm EDT (4:20 pm PDT) Scheduled time at Encore at the Wynn Hotel

Webcast replay window approximately 90 days Duration replay will be available after conference presentation

Previous Conferences,earnings date Reports

1 past event · Latest: Feb 09 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 09	Earnings date & conferences	Neutral	+0.3%	Set reporting date for FY 2025 results and outlined multiple conference appearances.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited history for this specific "conferences,earnings date" tag shows a small positive move on similar scheduling news.

Recent Company History

Recent news for Praxis highlights substantial clinical and regulatory momentum, including FDA acceptance and priority reviews for multiple NDAs and positive trial results, alongside a late‑stage CNS portfolio and strengthened balance sheet. Within this backdrop, prior "conferences,earnings date" news on Feb 9, 2026 about reporting results and attending conferences coincided with a modest 0.29% gain. Today’s announcement similarly schedules Q1 2026 results and conference participation, fitting into a pattern of regular investor‑facing updates following major pipeline milestones.

Key Terms

central nervous system, cns, biopharmaceutical, webcast

4 terms

central nervous system medical

"a fully integrated, leading central nervous system (CNS) precision neuroscience"

The central nervous system (CNS) is the body's main control center, made up of the brain and spinal cord, that processes information and directs movement, sensation and basic functions like breathing. For investors, CNS-related products and research matter because they face long development times, strict safety testing and regulatory hurdles; success or failure can dramatically affect a company’s costs, timelines and potential market value.

cns medical

"a fully integrated, leading central nervous system (CNS) precision neuroscience"

CNS stands for the central nervous system, the brain and spinal cord that control thought, movement and bodily functions. For investors, CNS-focused products and research matter because therapies aimed at this “delicate wiring” are scientifically challenging, often carry higher development and regulatory risk, and can take longer to prove safe and effective — but successful treatments also tend to command large markets and premium pricing.

biopharmaceutical medical

"precision neuroscience biopharmaceutical company, today announced it will report"

A biopharmaceutical is a medicine made from living organisms or their components—such as proteins, cells or genetic material—rather than chemically synthesized compounds. For investors, these products can command high prices and long patent protection but also carry bigger development, manufacturing and regulatory risks; think of them like handcrafted, high-tech products that can generate strong returns if they work, but are costly and complex to produce.

webcast technical

"The Company will host a conference call and a live webcast to review"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will report its financial results for the first quarter ended March 31, 2026, and provide a corporate update before the financial markets open on Thursday, May 7, 2026.

The Company will host a conference call and a live webcast to review the first quarter financial results and provide a corporate update on Thursday, May 7, 2026, at 8:30 am ET, which can be accessed by visiting this registration link. The live webcast will also be available on the Events & Presentations page of the Investors + Media section of the company’s website www.praxismedicines.com.

In addition, Praxis will be attending and presenting at the Bank of America Securities Health Care Conference. A corporate presentation will take place on Tuesday, May 12, 2026, at 7:20 pm EDT (4:20 pm PDT) at the Encore at the Wynn Hotel in Las Vegas, NV. A live webcast of the presentation will be available here. A replay of the webcast will be available after the event for approximately 90 days.

About Praxis  
Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across movement disorders and epilepsy, with four late-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on Facebook, Instagram, LinkedIn and Twitter/X.

Investor Contact: 
Praxis Precision Medicines 
investors@praxismedicines.com 
857-702-9452

Media Contact:
Dan Ferry
Life Science Advisors
Daniel@lifesciadvisors.com
617-430-7576

FAQ

When will Praxis Precision Medicines (PRAX) report Q1 2026 results and how can I access the call?

Praxis will report Q1 2026 results on May 7, 2026 at 8:30 am ET. According to the company, investors can access the conference call via a registration link and listen to a live webcast on the Events & Presentations page of the investor website.

What time and date is the Praxis (PRAX) presentation at the Bank of America Health Care Conference?

Praxis will present on May 12, 2026 at 7:20 pm EDT at the Encore at the Wynn in Las Vegas. According to the company, a live webcast will be available and a replay will remain online for about 90 days after the event.

Where can investors find the Praxis (PRAX) webcast replay after the May 7 and May 12 events?

Webcast replays will be available on the company investor website. According to the company, the May 12 conference replay will be posted and accessible for approximately 90 days after the presentation date.

Will Praxis (PRAX) provide a corporate update when reporting Q1 2026 results?

Yes, Praxis will provide a corporate update alongside its Q1 2026 financial results on May 7, 2026 at 8:30 am ET. According to the company, the update will be delivered during the conference call and live webcast for investors and analysts.

How can analysts register to attend the Praxis (PRAX) May 7 earnings webcast?

Analysts should register using the company’s provided registration link for the May 7, 2026 webcast. According to the company, registration and access information are available on the Events & Presentations page of the investor relations website.